[Form 4] Xos, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Emerald Green Trust, acting as a director-related reporting person for Xos, Inc. (XOS), reported three scheduled sales of common stock executed under a Rule 10b5-1 trading plan adopted May 27, 2025. The sales occurred on 08/29/2025 (19,731 shares at a weighted average price of $2.8889), 09/02/2025 (24,593 shares at $2.6191) and 09/03/2025 (19,333 shares at $2.4764). Following these dispositions the reporting person beneficially owned 1,637,197 shares. The filings state the price ranges for each sale date and note that full per-price breakdowns are available upon request.

Positive

• Transactions executed under a 10b5-1 plan, indicating pre-established trading instructions.
• Full weighted-average prices and price ranges disclosed with offer to provide per-price breakdowns on request.
• Form signed by trustee, showing formal authorization and compliance with filing requirements.

Negative

• Beneficial ownership decreased from 1,681,123 to 1,637,197 shares following the sales.
• Sales occurred at declining weighted-average prices across the three reported dates ($2.8889 to $2.4764).

Insights

Securities Analyst

TL;DR: Insider sold 63,657 shares under a pre-established 10b5-1 plan, reducing beneficial ownership to 1,637,197 shares.

The Form 4 discloses routine dispositions under a Rule 10b5-1 plan adopted May 27, 2025. The report provides weighted average prices and price ranges for each execution date and confirms the transactions were sales (code S). The filing is a standard Section 16 disclosure showing depletion of holdings from 1,681,123 to 1,637,197 shares across three dates but does not provide motives beyond the 10b5-1 plan. For investors this is a transparent, pre-planned disposition rather than an ad hoc sale.

Corporate Governance Expert

TL;DR: Reported trades were executed pursuant to a pre-existing 10b5-1 plan and were signed by the trustee.

The filing identifies Emerald Green Trust as the reporting person and shows the signature of Sarah Bardo as trustee dated 09/03/2025. The disclosure includes the relationship checkbox indicating a director and confirms the plan affirmative-defense box was checked. The document supplies the requisite weighted-average pricing and offers to provide detailed per-price sale breakdowns on request, meeting typical Form 4 compliance standards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Emerald Green Trust

(Last) (First) (Middle)

C/O XOS, INC.

3550 TYBURN STREET, UNIT 100

(Street)

LOS ANGELES CA 90065

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Xos, Inc. [ XOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		S		19,731(1)	D	$2.8889(2)	1,681,123	D
Common Stock	09/02/2025		S		24,593(1)	D	$2.6191(3)	1,656,530	D
Common Stock	09/03/2025		S		19,333(1)	D	$2.4764(4)	1,637,197	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025.

2. Represents weighted average sales price. The shares were sold at prices ranging from $2.84 to $3.00. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

3. Represents weighted average sales price. The shares were sold at prices ranging from $2.54 to $2.80. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

4. Represents weighted average sales price. The shares were sold at prices ranging from $2.39 to $2.61. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Sarah Bardo, Trustee for Emerald Green Trust	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What trades did Emerald Green Trust report for XOS on Form 4?

The trust reported three sales totaling 63,657 shares executed on 08/29/2025 (19,731 shares at $2.8889 weighted average), 09/02/2025 (24,593 shares at $2.6191) and 09/03/2025 (19,333 shares at $2.4764).

Were the sales part of a Rule 10b5-1 plan for XOS insider transactions?

Yes. The Form 4 indicates the transactions were effected pursuant to a previously established Rule 10b5-1 trading plan adopted May 27, 2025 and the affirmative-defense box was checked.

What was Emerald Green Trust’s beneficial ownership of XOS after these sales?

After the reported dispositions the filing shows the reporting person beneficially owned 1,637,197 shares of XOS common stock.

Who signed the Form 4 for Emerald Green Trust?

The Form 4 was signed by Sarah Bardo, Trustee for Emerald Green Trust on 09/03/2025.

Does the filing provide per-price sale details for each executed share?

The filing provides weighted-average prices and ranges for each date and states the reporting person will provide full information regarding the number of shares sold at each separate price upon request to the SEC, issuer or any security holder.